Reviva Pharmaceuticals Holdings (RVPH) Interest Expenses (2023 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) reported Interest Expenses of $2,935 for Q2 2026, down 38.8% from $4,797 a year earlier and down 55.9% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Interest Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Reviva Pharmaceuticals Holdings' Interest Expenses came in at $6,573, down 75.0% year-over-year; for FY2025, it came in at $13,402, down 27.5% from FY2024.
- Interest Expenses has a five-year compound annual growth rate of -60.8% (FY2020 to FY2025).
- By year, Interest Expenses came in at $18,497 in FY2024 (-45.2%) and $33,725 in FY2023.
- Five-year quarterly Interest Expenses spans a low of -$5,620 in Q4 2025 and a high of $13,311 in Q4 2023.
- Year over year, Interest Expenses gained in 1 of the last seven quarters, with growth averaging 2.6%.
- The high point for year-over-year Interest Expenses in five years was Q1 2025 (growth of 233.2%); the low point was Q4 2024 (a decline of 64.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6,653 (Q1 2026), -$5,620 (Q4 2025) and $2,605 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Reviva Pharmaceuticals Holdings | 6.16 Mn | 6.16 Mn | - | 2,935.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,935.00 |
| Mar 31, 2026 | 6,653.00 |
| Dec 31, 2025 | -5,620.00 |
| Sep 30, 2025 | 2,605.00 |
| Jun 30, 2025 | 4,797.00 |
| Mar 31, 2025 | 11,620.00 |
| Dec 31, 2024 | 4,711.00 |
| Sep 30, 2024 | 5,146.00 |
| Jun 30, 2024 | 5,153.00 |
| Mar 31, 2024 | 3,487.00 |
| Dec 31, 2023 | 13,311.00 |
| Sep 30, 2023 | 5,901.00 |
| Jun 30, 2023 | 12,759.00 |
| Mar 31, 2023 | 7,655.00 |
API Access
Reviva Pharmaceuticals Holdings Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();